U.S. market Closed. Opens in 1 day 10 hours 13 minutes

HUGE | FSD Pharma Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312017-11-302017-08-312016-08-312015-08-31
RevenueN/AN/AN/AN/A196.82K65.17K20.63K20.63KN/AN/AN/A
Cost of Revenue2.55M4.36M4.01M4.11M2.04MN/AN/AN/AN/AN/AN/A
Gross Profit-2.55M-4.36M-4.01M-4.11M-1.84M65.17K20.63KN/AN/AN/AN/A
Operating Expenses17.38M27.43M33.74M30.60M25.98M18.62M2.82M2.82M19.37K29.63K32.80K
Selling, General & Admin13.45M15.98M23.37M18.11M22.86M18.19M2.82M2.82M19.37K29.63K32.80K
Research & Development3.93M6.91M6.33M7.83MN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A4.54M4.05M4.66M3.12M-401.90KN/AN/AN/AN/AN/A
Operating Income-19.93M-27.43M-33.74M-30.69M-28.07M-20.44M-2.82M-2.80M-19.37K-29.63K-32.80K
Other Expenses / Income1.36M725.95K-194.30K2.24M-11.75M1.88M-2.80MN/AN/AN/AN/A
Before Tax Income-18.56M-26.70M-33.94M-28.45M-39.82M-16.67M-2.80M-2.80M-19.37K-29.63K-32.80K
Income Tax Expenses-1.00-3.38M1.47M4.27M235.16K-3.77MN/AN/AN/AN/AN/A
Net Income-18.56M-23.32M-35.41M-32.72M-40.05M-16.67M-2.80M-2.80M-19.37K-29.63K-32.80K
Interest Expenses304.0048.82K69.40K235.58K158.05KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding39.59M38.73M34.95M12.04M7.06M5.91M6.57M6.57M6.57M6.57M6.57M
Diluted Shares Outstanding39.59M38.73M34.95M12.04M7.06M5.91M6.57M6.57M6.57M6.57M6.57M
EBITDA-17.38M-22.41M-29.65M-26.02M-25.34M-20.31M-2.80M-2.80M-19.37K-29.63K-32.80K
EBITDA Margin0.00%0.00%0.00%0.00%-12,872.31%-31,158.08%-13,585.61%-13,585.61%0.00%0.00%0.00%
EBIT-18.56M-26.65M-33.87M-28.22M-39.66M-20.44M-2.80M-2.80M-19.37K-29.63K-32.80K
EBIT Margin0.00%0.00%0.00%0.00%-20,150.52%-31,364.47%-13,585.61%-13,585.61%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312017-11-302017-08-312016-08-312015-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙